Moelis & Co insider trading
Every open-market purchase and sale by Moelis & Co's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Moelis & Co’s insiders pay?
From November 26, 2014 to August 31, 2026, 11 insiders reported 0 open-market purchases and 149 sales not made under a pre-set plan in Moelis & Co. After sales, the shares moved +6.7% against the index over 12 months (a negative figure means selling was the right call).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Moelis Kenneth | Chairman, CEO | 0 | — | — | 22 | +6.8% (22) | February 21, 2025 |
| Mahmoodzadegan Navid | Co-President, MD | 0 | — | — | 21 | +9.5% (21) | February 21, 2025 |
| Raich Jeffrey | Co-President, MD | 0 | — | — | 20 | +11.3% (20) | February 21, 2025 |
| Watanabe Osamu R. | General Counsel, Secretary | 0 | — | — | 20 | +5.2% (18) | August 6, 2026 |
| Simon Joseph | Chief Financial Officer | 0 | — | — | 17 | +14.7% (17) | February 21, 2025 |
| Crain Elizabeth | Chief Operating Officer | 0 | — | — | 16 | +7.6% (16) | August 2, 2023 |
| Callesano Christopher | Principal Accounting Officer | 0 | — | — | 13 | +3.8% (13) | February 21, 2025 |
| Shropshire Kenneth | Director | 0 | — | — | 8 | −14.7% (7) | August 31, 2026 |
| Leaman J Richard III | MD & Vice Chairman | 0 | — | — | 7 | +2.2% (7) | April 26, 2018 |
| Pilcher Ciafone Katherine | Chief Operating Officer | 0 | — | — | 3 | −3.1% (3) | February 21, 2025 |
| Cantor Eric | Vice Chairman, MD | 0 | — | — | 2 | −3.3% (2) | February 21, 2025 |
When several insiders traded Moelis & Co
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Moelis & Co in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 13 selling crowds, +7.9%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| February 28, 2025 | 9 selling | −17.7% | −4.9% | −29.3% |
| July 31, 2024 | 3 selling | −5.7% | +7.3% | −8.9% |
| February 29, 2024 | 8 selling | +2.3% | +15.4% | +9.4% |
| February 28, 2023 | 6 selling | −14.5% | +1.0% | +3.1% |
| February 28, 2022 | 5 selling | +3.1% | −1.5% | +2.3% |
| February 26, 2021 | 5 selling | −2.1% | +7.9% | −10.6% |
| October 30, 2020 | 3 selling | +30.3% | +28.3% | +89.7% |
| June 30, 2020 | 3 selling | +2.4% | +36.3% | +65.1% |
| November 29, 2019 | 5 selling | +0.6% | +11.2% | +9.1% |
| May 31, 2019 | 6 selling | +0.9% | −7.7% | +0.4% |
| February 28, 2018 | 8 selling | +17.1% | +12.8% | −7.4% |
| February 28, 2017 | 8 selling | −3.0% | +8.9% | +35.4% |